http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111551546-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2021-0112
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
filingDate 2020-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2023-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2023-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111551546-B
titleOfInvention A convenient immunohistochemical detection method based on optical microcavity metamaterials
abstract The invention discloses a convenient immunohistochemical detection method based on an optical microcavity structure metamaterial. The method comprises the following steps: 1) preparing a metamaterial with an optical microcavity structure on a substrate; 2) modifying one or more antibodies of tumor markers on the metamaterial to obtain a metamaterial immunochromogenic device; 3) Collect the image data and spectral data of the chromogenic device; 4) attach the tumor tissue slice to the chromogenic device, and let it stand still so that the antibody can specifically bind to the chromogenic device; 5) remove the tumor tissue slice, and collect the supermaterial immunostaining The image data and spectral data of the tissue slice bonding area on the color device are compared with the data collected in step 3), so as to obtain the distribution of tumor cells in the tumor tissue slice. The metamaterial used in the present invention has the characteristics of structural color, can replace the staining step in immunohistochemistry, greatly simplifies the current operation of immunohistochemistry, shortens the detection time of immunohistochemistry, and is expected to realize intraoperative detection.
priorityDate 2020-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013186374-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22440003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426252242

Total number of triples: 20.